Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Risk/Benefit Of Asthma Drugs To Be Debated At Future Advisory Committee

Mar 06 2008

• By Lauren Smith

Related Content

FDA Uncertain About GSK’s Serevent Pediatric Risk-Benefit Ratio

Nov 27 2007

Serevent, Advair, Foradil Withdrawals To Be Considered By Advisory Committee

Jul 12 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window